Kala Pharmaceuticals (NSDQ:KALA) said today that it closed its initial public offering of 6.9 million shares of common stock.
The Waltham, Mass.-based company priced its public offering at $15.00 per share, granting underwriters an option to buy up to 900,000 additional shares. The exercise of this option brought the proceeds of its IPO up from $90 million to $103.5 million, Kala reported.
Get the full story at our sister site, Drug Delivery Business News.
The post Kala nabs $104m in IPO appeared first on MassDevice.